Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€165.05
08.07.21
-
08.07.22
7.24%
08.07.22

Prof 
08.07.21 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€107.60
08.07.21
-
08.07.22
-18.17%
08.07.22

Prof 
08.07.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.21
08.07.21
€55.00
08.07.22
29.12%
18.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
08.07.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.86
08.07.21
€177.00
08.07.22
22.71%
08.07.22

gerihouse 
08.07.21 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
sell
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€488.40
15.06.21
-
15.06.22
-27.06%
21.05.22

EBIT growth >5% per year expected
Very low/no dividend yield expected
GraveDigger 
15.06.21 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€320.85
08.06.21
€330.00
08.06.22
-41.88%
08.06.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Top 10 in its market
Well known brand
tbackenh 
08.06.21 80%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€49.93
07.06.21
€55.00
07.06.22
42.14%
08.06.22

Could be worthwhile Investment >10% per year
melinda 
07.06.21 50%
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€238.80
07.06.21
€250.00
29.04.22
15.03%
30.04.22

Could be worthwhile Investment >10% per year
melinda 
07.06.21 50%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€370.00
01.05.21
-
01.05.22
-5.65%
02.09.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
NightTrain 
01.05.21 50%
buy
Centene Corp.

Start price
Target price
Perf. (%)
€51.00
01.05.21
€56.00
01.05.22
50.31%
02.05.22

Could be worthwhile Investment >10% per year
melinda 
01.05.21 50%
sell
Abiomed Inc.

Start price
Target price
Perf. (%)
€266.60
29.04.21
€245.00
29.04.22
-10.43%
07.06.21

Could be worthwhile Investment >10% per year
melinda 
29.04.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.02
06.04.21
€60.00
06.04.22
3.82%
01.07.21

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
06.04.21 70%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€152.98
25.03.21
€140.00
25.09.21
25.83%
28.06.21

Could be worthwhile Investment >10% per year
Known brand
Medium risks for its business
overvalued
Snowman 
25.03.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€136.62
24.03.21
€145.00
24.03.22
-1.26%
09.04.21

Known brand
Future proof or reliable business model
Medium risks for its business
phonebroker 
24.03.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€50.00
15.03.22
43.43%
09.11.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
15.03.21 80%
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€101.00
09.03.21
€120.00
09.03.22
19.46%
10.03.22

Could be worthwhile Investment >10% per year
melinda 
09.03.21 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€130.34
27.02.21
-
27.02.22
37.81%
20.01.22

Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Troubadour 
27.02.21 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€64.63
25.02.21
€70.00
3.84%
08.03.21

Could be worthwhile Investment >10% per year
Traumtanz 
25.02.21 50%
sell
Incyte Corp.

Start price
Target price
Perf. (%)
€67.64
24.02.21
-
24.02.22
-12.39%
25.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
SpringheelJack 
24.02.21 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€62.50
24.02.21
-
24.02.22
1.60%
30.03.21

Probably not worthwhile Investment
tinelchen 
24.02.21 0%
sell
Teleflex Inc.

Start price
Target price
Perf. (%)
€320.00
21.02.21
-
21.02.22
14.38%
23.04.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
CrazyEights 
21.02.21 50%
sell
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€416.00
06.02.21
-
06.02.22
7.91%
25.05.21

EBIT growth >5% per year expected
Very low/no dividend yield expected
GraveDigger 
06.02.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€138.90
05.02.21
-
31.12.21
0.09%
29.03.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Gilbert 
05.02.21 50%
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€222.00
01.02.21
€260.00
30.03.22
-6.17%
09.10.21

Ronald 
01.02.21 80%